CarpeDiab - Integrated e-health solution for self-management of type 2

CarpeDiab aims to be an advanced service for type 2 diabetes management. The project, which has received funding from the European Union's Horizon 2020, expects to have an impact on the behaviour of patients and healthcare professionals to take full advantage of the possibility that technology opens.

IDF Europe is part of the consortium that brings expertise from 6 European countries: Italy, The Netherlands, Turkey, Spain, Belgium and Germany, which leads it.

CarpeDiab will continue its activity in 2019.  For more information, please visit: https://proempower-pcp.eu/pcp-contractors/carpediab.html